Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 50% decrease from the number of companies cited in the previous quarter.
The citations in the county include:
- Management with executive responsibility has not reviewed the suitability and effectiveness of the quality system at defined intervals.
- Procedures for monitoring and control of process parameters for a validated process have not been adequately established.
- Procedures for corrective and preventive action have not been adequately established.
Most of the companies cited were involved in the Devices sector.
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Hangtime | Food and Cosmetics | 12/13/2024 | Process deviation evaluation - record |
Hangtime | Food and Cosmetics | 12/13/2024 | Raw materials, packaging, finished product |
Hangtime | Food and Cosmetics | 12/13/2024 | Maintenance of processing and production records |
Hangtime | Food and Cosmetics | 12/13/2024 | Equipment and utensils - Design and maintenance |
NeuroOne Medical Technologies Corporation | Devices | 10/28/2024 | Design Validation - Risk analysis not performed/inadequate |
NeuroOne Medical Technologies Corporation | Devices | 10/28/2024 | Design validation- Lack of or inadequate procedures |
Pathy Medical, LLC | Devices | 11/19/2024 | Management review - defined interval, sufficient frequency |
Pathy Medical, LLC | Devices | 11/19/2024 | Lack/Inad procedure-Monitoring/Control of Validated Proces |
Pathy Medical, LLC | Devices | 11/19/2024 | Lack of or inadequate procedures |